Literature DB >> 19799237

[Infectious diseases in Poland in 2007].

Andrzej Zieliński1, Mirosław P Czarkowski.   

Abstract

The fact that incidence of infectious diseases in Poland is quite stable and, as compared with many noninfectious diseases relatively better, should not lead to underestimation of the problem. Despite in many diseases long term trends indicate decreasing incidence, in some important diseases increase of incidence was noted. Significant decrease was noted in incidence of some diseases for which vaccination program was modified. It concerns mumps, Hib infections, and to some extend also pertussis. Serious problem remains with accumulated through several years high prevalence of hepatitis B and C. Also low vaccine coverage of influenza is a measure of weakness of prevention against this disease, which is one of the most important causes of job and school absence and despite low mortality, is one of important caused of increased mortality in winter season. Next important epidemiological problem cause bacterial and viral foodborne infections, which despite some improvement place Poland below average of EU. Also relative stabilization of the incidence of tuberculosis does not look good if compared with leading countries of EU. With HIV infections particular concern is brought by the number of late diagnoses and drastic decline of data on the probable risk factor of infection. Infectious diseases mortality in 2007 was 6.6/100,000 (3.5 in Podlaskie Voivodeship and 9.3 in Slaskie) and it was higher in cities (7.1) then in rural areas. As in previous years i man mortality (8.6) was higher then in women (4.9). Highest mortality from infectious diseases was noted among elderly people above 74 (30.6).

Entities:  

Mesh:

Year:  2009        PMID: 19799237

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  1 in total

1.  A novel, nested, multiplex, real-time PCR for detection of bacteria and fungi in blood.

Authors:  Tomasz Gosiewski; Danuta Jurkiewicz-Badacz; Agnieszka Sroka; Monika Brzychczy-Włoch; Małgorzata Bulanda
Journal:  BMC Microbiol       Date:  2014-06-04       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.